Asacol HD has been evaluated in 896 patients with ulcerative colitis in controlled studies.The most common reactions in patients with moderately active ulcerative colitis (602 patients dosed with Asacol HD and 618 patients dosed with mesalamine delayed-release 400 mg) were the same as all...